Amgen To Pay $74M To End Investor Suit Over $10.7B Tax Bill
Pharmaceutical giant Amgen has agreed to pay $74 million to resolve an investor class action alleging it hid a $10.7 billion tax bill from shareholders, according to an agreement filed in...To view the full article, register now.
Already a subscriber? Click here to view full article